Isis Pharma receives US$ 10 mn from OncoGenex' license of OGX-O11 to Teva
Monday, December 28, 2009 14:00 IST Carlsbad, California
Isis Pharmaceuticals, Inc will receive a US$ 10 million payment from OncoGenex Pharmaceuticals, Inc as a result of OncoGenex' license of OGX-011 to Teva